The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

PDL BioPharma Completes Regular Quarterly Dividend Payment

Wednesday, June 12, 2013

PDL BioPharma Completes Regular Quarterly Dividend Payment

16:02 EDT Wednesday, June 12, 2013

INCLINE VILLAGE, Nev., June 12, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the June 12, 2013, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of June 5, 2013, the record date.

(Logo:  http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

About PDL BioPharma PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.

For further information: Peter S. Garcia, PDL BioPharma, Inc., 775-832-8500, peter.garcia@pdl.com or Jennifer Williams, Cook Williams Communications, Inc., 360-668-3701, jennifer@cwcomm.org

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections